Innventure, Inc. To Announce Third Quarter 2025 Results On November 13, 2025

2025-11-11 04:16:16

(MENAFN- GlobeNewsWire - Nasdaq) ORLANDO, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industrial growth conglomerate, today announced it will release its third quarter 2025 financial results after market close on Thursday, November 13, 2025. Management will host a conference call on the day of the release (November 13, 2025) at 5:00 pm ET to discuss the results.

The event will be webcasted live via our investor relations website or via this link.

Parties interested in joining via teleconference can register using this link

After registering, you will be provided dial in details and a unique dial-in PIN. Registration is open through the live call, but to ensure you are connected for the full call, we suggest registering in advance.

About Innventure
Innventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, focuses on building companies with billion-dollar valuations by commercializing breakthrough technology solutions. By systematically creating and operating industrial enterprises from the ground up, Innventure participates in early-stage economics and provides industrial operating expertise designed for global scale. Innventure's approach seeks to uniquely bridge the”Valley of Death" between corporate innovation and commercialization through its distinctive combination of value-driven multinational partnerships, operational experience, and scaling expertise.

Media Contact: Laurie Steinberg, Solebury Strategic Communications
...

Investor Relations Contact: Sloan Bohlen, Solebury Strategic Communications
...

MENAFN11112025004107003653ID1110329223

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.